Cardiovascular enterprise viewer sales will expand through 2036, with diagnostic and monitoring devices holding 65.0% of the device segment in 2026. Coronary artery diseases lead the application segment with a 48.0% share. The market is projected to reach USD 349.4 million in 2026 and USD 507.3 million by 2036.